个性化医疗:临床瘤学对治疗的分子视图
Rafick Costa Dos Santos Da Silva1, Nathalia de Andrade Simon1, André Alves Dos Santos1
1Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória Da Conquista 45029-094, Bahia, Brazil.
World journal of clinical oncology
|August 28, 2024
概括
精准医学使用基因绘图和生物标志物来针对癌症治疗. 生物信息学和液体活检增强了诊断和早期检测,改善了患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 癌症是导致死亡的主要原因,对身体和情绪产生重大影响.
- 传统治疗有不良影响,需要更精确的治疗策略.
- 精准医学提供基于个体分子形状的有针对性的治疗方法.
研究的目的:
- 在临床使用中审查癌症治疗的分子视角.
- 探索生物标志物和生物信息学在癌症诊断和预后中的作用.
- 为了突出精准医学在个性化癌症治疗方面的进步.
主要方法:
- 对分子生物学方法的审查,包括遗传映射.
- 关键生物标志物的分析,如α-fetoprotein和编程死亡-1.
- 强调生物信息学,人工智能和液体活检技术.
主要成果:
- 生物标志物提供有价值的预后和诊断信息.
- 生物信息学和人工智能使更准确的诊断和数据分析成为可能.
- 精准医学,以乳腺癌亚型为例,指导个性化治疗策略.
结论:
- 精准医学根据分子瘤特征量身定制治疗方法,提高疗效.
- 成本和瘤异质性等挑战需要合作解决方案.
- 分子生物学的进步旨在使个性化癌症护理对所有人来说都可用.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer
48.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.2K
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493


